content (Levine et aI., 1965) . Furthermore, chemical Turnover of cerebral histamine is influenced by both environmental and endogenous factors. Its levels are reduced by restraint, cold stress, and anesthesia (Taylor and Snyder, 1971; Pollard et aI. , 1973; , and are increased during the arousal period of a 24-h cycle (Orr and Quay, 1975) . His tamine metabolism is a rapid process, as would be expected for a neurotransmitter. Estimates of half lives are shorter than Ih (Pollard et aI. , 1974; Schwartz et aI. , 1980b) and possibly as short as 30 s (Dismukes and Snyder, 1974) .
Histamine is localized in at least two storage compartments in brain. The mast cells, which richly invest the meninges and perivascular spaces (Ib rahim, 1974; Edvinsson et aI. , 1977; Jarrott et aI. , 1979; Head et aI. , 1980) , are almost certainly the least important store for neuronal function. Mast cells are not commonly found in the neuropil (Ed vinsson et aI. , 1977) , and are not normally respon sive to neural stimuli (Goth and Johnson, 1975) .
Mast cells probably have an important role in cere brovascular function (see below), especially in pathological conditions involving vascular injury (Beaven, 1978) .
In the earlier assays for cerebral histamine, it was J Cereb Blood Flow Metabol, Vol. 2, No. 1, 1982 not clear whether the measured amine originated from mast cells or neurons (Kwiatkowski, 1943; Adam and Hye, 1966) . Centrifugation techniques, however, particularly subcellular fractionation, re vealed that a large proportion of histidine decar boxylase and histamine is associated with the synaptosomal fraction, i. e. , small nerve endings (Kataoka and De Robertis, 1967; Schwartz et aI. , 1970; Taylor and Snyder, 1972a; Schayer and Reilly, 1973) . When rat brain synaptosomes are shocked by hypo-osmotic solutions, for example, significant quantities of histidine decarboxylase are liberated (Baudry et aI. , 1973; Snyder et aI. , 1974) . These results suggest that histamine's synthesizing en zyme is present in the cytoplasm of brain nerve endings (Schwartz et aI. , 1980b) . Studies of synap tosomal fractions have also shown the synthesis in vivo of 3H-histamine from 3H-histidine (Pollard et aI. , 1974) and the presence of histamine N methyltransferase (Kuhar et aI. , 1971; Snyder et aI. , 1974) .
Thus, the primary marker for cerebral his taminergic nerves, histidine decarboxylase, derives mainly from neuronal components (Garbarg et aI. , 1976; Schwartz et aI. , 1980b) . The activity of the enzyme is very low in mast cells where the rate of histamine turnover is slowest (Garbarg et aI. , 1976; Jarrott et aI. , 1979) . These facts form a basis for estimating the relative pool sizes of neuronal and non-neuronal histamine in the brain. In rat cerebral cortex, about 50% of recovered histamine is neuronal (Garbarg et aI., 1976) while in other regions where histaminergic fibers may be more densely distributed, such as in the hypothalamus and hip pocampus, the percentage of neuronal histamine is likely to be higher (Schwartz et aI. , 198Ob) .
To establish a general picture of histamine dis tribution in the brain, however, the following categories may be used: histamine content is high est in the hypothalamus, which itself has a hetero geneous concentration of the amine (Brownstein et aI. , 1974) ; intermediate levels are found throughout the telencephalon; and the lowest levels occur in the brainstem and cerebellum (Taylor and Snyder, 1972b; Taylor et aI. , 1972) .
Recent ligand-binding studies using 3H-mepyr amine to identify cerebral HI-receptors autora diographically have provided additional informa tion about the presence of histamine in the brain (Palacios et aI. , 1981) . These studies indicate a greater density of Hcreceptors in gray, as opposed to white, matter, and a marked inter-and intrare gional heterogeneity of receptors bound by 3H mepyramine. Identification of cerebral H2-receptors using the ligand 3H -cimetidine has not yet provided the same fine spatial resolution (Burkhard, 1978) .
Putative Pathways
A compelling line of evidence to substantiate histamine as a neurotransmitter would be to demon strate histochemically the anatomical disposition of its nerves. Unfortunately, there appears to be no reli able method available for such studies. (Sastry and Phillis, 1976; Haas and Wolf, 1977) .
Preliminary studies, using local injections of kainic acid to destroy neuronal cell bodies, indicate the possible existence of another histaminergic pathway to the cerebral cortex emanating from the midbrain tegmentum (Schwartz et aI. , 198Ob) .
The possibility also exists that histaminergic neurons have a very localized organization for highly specific functions. For example, histamine appears to be involved in some secretory mecha nisms in the pituitary gland (Weiner and Ganong, 1978) . The following summary of criteria that have been met, however, will serve to strongly implicate his-.
tamine as a mediator of cerebral neuronal function.
Some of the points have been itemized above, but will be listed again here to unify the presentation.
The regional patterns of distribution of histamine, its metabolic enzymes, and its receptors are non uniform in the brain; histidine decarboxylase, his tamine, and histamine N-methyltransferase can be found in subcellular fractions containing synapto somes; electrical and chemical lesions of certain brain areas reduce histidine decarboxylase activity and histamine content in distal structures; and his tamine can be released from cerebral tissue slices by K+-stimulated depolarization, a process that is dependent on both temperature and calcium (Atack and Carlsson, 1972; Taylor and Snyder, 1973; Ver diere et aI., 1975; Subramanian and Muelder, 1976) .
Furthermore, the ontogenetic development of histamine nerves and receptors in the brain appears to be a coordinated process that is consistent with expected patterns of maturation for a neurotrans mitter. During growth, the proliferation of cerebral Hereceptors (identified by 3H-mepyramine binding) parallels the increasing activity and concentration of histidine decarboxylase and neural histamine, re spectively (Tran et aI., 1980; Subramanian et aI., 1981) . In aged animals, the amount of cyclic AMP formed from histamine-activated adenylate cyclase is substantially reduced compared to young adults.
These results are consistent with the view that re ceptor atrophy or desensitization occurs with aging (Makman et aI., 1979) .
The remaining criteria deserve special attention, and can be grouped into two categories of studies, those demonstrating that histamine stimulates for mation of cyclic nucleotides, such as 3' ,5' -cyclic adenosine monophosphate (cyclic AMP), and those demonstrating electrophysiological responses of isolated nerve cells to applied histamine.
Influence on Cyclic Nucleotide Synthesis
Cyclic AMP may be a "second messenger" at neuronal synapses in the brain (Bloom, 1975; Daly, 1976; Nathanson and Greengard, 1977) . It has been shown to participate in adrenergic neurotransmis sion in Purkinje and pyramidal cells (Bloom, 1975) , and may have a much broader role in the central nervous system in view of its spectrum of diverse Histamine can also stimulate formation of cyclic guanosine 3'-5' -monophosphate in neural tissues.
This process is dependent on the cellular transloca tion of calcium and is mediated exclusively by He receptors ( Fig. 2) (Richelson, 1978; Study and Greengard, 1978; Chang and Snyder, 1980) . Fur thermore, it appears to be part of a potent glycogenolytic mechanism that is selectively linked to the HI class of histamine receptors in brain (Schwartz, 1979; Quach et aI., 1980) .
Electrophysiological Studies
If histamine functions as a cerebral neurotrans mitter, then the firing rate of its putative neurons should be affected when the amine is administered peri neurally by microiontophoretic application. As suming that cerebral receptors for histamine are the same as those in peripheral organs, any such action should be antagonized by histamine receptor blocking agents.
Schematic diagram of a synapse for hypothetical histaminergic neurons. (1) Histamine (HA) is released from presynaptic vesicles in the nerve ending; (2) Primarily through H2-receptors, histamine stimulates the activity of adenylate cy clase, which synthesizes cAMP from ATP; (3) Histamine also interacts with H,-receptors which probably mediate the formation of cGMP (Richelson, 1978; Quach et aI., 1980; Chang and Snyder, 1980) . Adapted from Schwartz et aI., 1976 and Schwartz, 1979 .
Four kinds of responses to histamine have been described from studies of mammalian CNS prepa rations. Inhibition of neuronal firing rate, charac terized by both rapid onset and recovery, is the most typical response, occurring in neurons in ce rebral cortex (Phillis et aI. , 1968; Sastry and Phillis, 1976) , the midbrain reticular formation (Haas et aI. , 1973) , hippocampus (Haas and Wolf, 1977) , and in the ventromedial and preoptic nuclei of the hypothalamus (Renaud, 1976; Carette, 1978) . In hibitory responses with slow phases of onset and recovery were identified in the hypothalamic preoptic area (Carette, 1978) . Cells of hypothalamic nuclei have exhibited excitatory responses with both slow and rapid time-courses (Haas and Wolf, 1977; Carette, 1978 (Phillis et aI. , 1968; Haas, 1974; Sastry and Phillis, 1976 ). The interpretation is confounded, however, because Heantihistamines have membrane stabi lizing properties which may produce nonspecific effects (Schwartz, 1977) . identified (Carpenter and Baubatz, 1975; Weinreich et aI. , 1975) . " The concentration of histamine in some hypothalamic nuclei is elevated in spontaneously hypertensive rats (Correa and Saavedra, 1981) .
Hypothalamus: Neuroendocrine and Vegetative

Functions of Histamine
It is now certain that the hypothalamus is the re gion with the highest content of histamine in the brain (Taylor and Snyder, 1972b; Taylor et aI. , 1972) . Table 2) .
Functions for histamine other than those listed in 
Related Pharmacology
The complexity and heterogeneity of synaptic functions in the brain may include interactions be tween two or more neurotransmitter substances. It is worthwhile to consider, therefore, mechanisms and responses involved when psychotropic drugs interact with cerebral histamine receptors. These agents often have a wide spectrum of activity in fluencing more than one transmitter system (Snyder and Bennett, 1976; Hollister, 1978; Green et aI. , 1980) . In the following sections, agents having po tent effects on CNS function, and, in particular, having an affinity for neural histamine receptors, will be presented.
Clonidine
Clonidine is a potent antihypertensive agent whose effects are thought to be mediated by central 
Reserpine
Reserpine stimulates release of histamine from brain slices in vitro (Taylor and Snyder, 1973 tamine (Tran et aI. , 1978) . This spatial incongruity applies as well to other neurotransmitters whose function may be altered by antidepressants, such as norepinephrine, GAB A (y-aminobutyric acid), and dopamine (Snyder and Bennett, 1976) . 
Inhibition of Metabolic Enzymes
The synthesis and catabolism of cerebral his tamine in mammals are simple one-step processes, mediated by the enzymes histidine decarboxylase and histamine N-methyltransferase, respectively ( Fig. 1 ; Schayer and Reilly, 1973; Snyder et aI. , 1974; Douglas, 1975) . (Table 2 ).
Summary and Indications
There is considerable evidence to strengthen the Where histamine mechanisms are clear, however, it would be valuable to define their effects on mea surable metabolic parameters in brain, such as phospholipid turnover (Subramanian et aI., 1981) , glucose utilization (Sokoloff, 1981b) , and local synthesis of protein (Kennedy et aI., 1981) .
VASCULAR REGULATION Cerebral Blood Flow
The effect produced by histamine in the cerebral circulation is still a matter of controversy despite decades of interest. In a previous review (Sokoloff, 1959) and in more recent papers and textbooks (Douglas, 1975; Ryan and Ryan, 1978; Leibowitz, 1979) , histamine has been reported to be a potent dilating agent in the brain circulation. Dilatation re sulting from intravascular administration of this amine is difficult to understand, however, because histamine itself is impermeable at the blood-brain barrier (Snyder et aI., 1964; Oldendorf, 1971 ).
In the last 10 years, there have been several studies in monkeys, dogs, and cats that reported an increase in cerebral blood flow resulting from his tamine infusion. Critical appraisal of these reports, however, reveals the following potential limitations:
(1) flow measurements were obtained from large extracranial vessels supplying the brain (Saxena, 
Responses of Pial Arterioles and Veins In Situ
Because of its accessibility, the pial circulation has provided considerable information about re sponses of brain vessels to drugs (Kuschinsky and Wahl, 1978) . When histamine is administered by perivascular injection, pial arterioles always respond with dila tation that is concentration-dependent (Wahl and Kuschinsky, 1979) . Similarly, in vitro, histamine causes relaxation of precontracted middle cerebral arteries (Edvinsson and Owman, 1975) .
The studies by Wahl and Kuschinsky (1979) also indicated that nearly all of the pial arteriolar dilata tion in response to histamine resulted from interac tion with H2-receptors. This finding introduced the possibility that there is a differential distribution of histamine He and H2-receptors in cerebral ar teries, i.e., H2-receptors are more densely popu lated in outer layers of arteriolar smooth muscle, a spatial arrangement that may also exist in skeletal muscle and cutaneous arteries (Powell and Brody, 1976b; Galeno et aI., 1979) . In this hypothesis, He receptors may be present in arteriolar smooth mus cle, but are preferentially localized within inner layers (Brody, 1980) 1968, 1970, 1972, 1979) . Studies in peripheral vas cular beds of vasoactive agents, including his tamine, indicate that the precapillary resistance vessels are generally more responsive to these stimuli than capacitance vessels and, in fact, the vascular segments may have opposite responses to the same stimulus (Abboud et aI., 1976) . In skeletal muscle and skin preparations, histamine may con strict (Haddy, 1960; Powell and Brody, 19700) 
Interaction of Histamine with Vascular Noradrenergic Mechanisms
Histamine is synthesized and/or stored in au tonomic nerves (Ryan and Brody, 1970) . It is richly concentrated in postganglionic sympathetic nerves (Ryan and Brody, 1970) and is avidly sequestered by sympathetic axons in rabbit iris (Ehinger, 1974) .
Although not yet demonstrated histochemically, these findings suggest that histamine may be pres ent in cerebrovascular sympathetic nerves and may play a role in modulating nervous activity at the sympathetic neuro-effector junction.
Using rabbit basilar arteries in vitro, Bevan et al. (1975) showed that histamine could modify vascular responses to transmural nerve stimulation and ex ogenous norepinephrine. Similar responses have been found in the rabbit ear artery (Foldes and Hall, 1979; Casteels and Suzuki, 1980) and rabbit ganglia (Brimble and Wallis, 1973) The organization and function of histamine re ceptors at sympathetic nerve endings appear to be complex because H2-receptors, in contrast to Hr receptors, inhibit rather than facilitate adrenergic mechanisms in heart (Lokhandwala, 1978) , blood vessels (McGrath and Shepherd, 1976; Powell, 1979) and ganglia (Brimble and Wallis, 1973) . How several transmitter substances may affect synaptic neurotransmission in blood vessels and other tis sues has been discussed by Starke et ai. (1977) . (5) histamine. B illustrates the liberation of histamine either from sympathetic nerves Brody, 1970, 1972) , mast cells (Goth and Johnson, 1975; Brody et aI., 1979) , or a non-mast cell store in vascular smooth muscle (Heitz and Brody, 1975) during activation of the sympathetic nerves. In C, the avail able histamine interferes post-synaptically with norepineph rine at the adrenergic receptor sites. As suggested in the present analysis and in the studies by Powell (1979) , this in hibitory mechanism is mediated by H2-receptors in arterioles, but does not apply to pial veins in situ. D shows histamine interacting with histamine receptors in smooth muscle. By itself, this mechanism produces dilatation of pial arterioles (Wahl and Kuschinsky, 1979) , but no response in veins (Gross et aI., 1981c) . E depicts the prejunctional inhibitory mecha nism involving histamine. Histamine liberated from any of three possible sources interacts at prejunctional sites, and probably inhibits the release of transmitter (Powell, 1979) . H,-receptors (McGrath and Shepherd, 1976; Powell, 1979) , and H,-receptors in both arterioles and veins (Gross et aI., 1981e) . participate in this mechanism.
contrast, if released when sympathetic activity is high, as in neurogenic hypertension (Gross et aI. , 1979), histamine would tend to diminish rather than potentiate cerebral vascular responses to sympa thetic nerve stimulation.
The involvement of histamine in autonomic ner vous mechanisms in peripheral vascular beds has been discussed previously by Brody and colleagues (Ryan and Brody, 1972; Brody et aI., 1979) . Figure 3 illustrates possible relationships between histamine receptors and noradrenergic stimuli in cerebral ves sels.
In conclusion, histamine probably inhibits noradrenergic transmission in pial vessels. It re mains to be discovered whether this type of inter ference occurs at steps involving secretory-effector coupling, transmitter metabolism, or a trans synaptic feedback loop (Frame and Hedqvist, 1975; Starke et aI., 1977) .
Blood-Brain Barrier
In qualitative studies published some thirty years ago, it was demonstrated that histamine could in crease the passage from blood into brain of the dye, 103), had increases in permeability of similar mag nitude. Furthermore , the effect was regional , was reversible over time, and was mediated principally by H2-receptors. Histamine caused an increase in cortical water content , and electron microscopic studies showed that pericapillary astroglial pro cesses were swollen , a finding consistent with cere bral edema formation (Wolff et aI. , 1975; Bourke et aI. , 1980) . Further microscopic analyses revealed that endothelial tight junctions did not contain horse radish peroxidase , but reaction product was pres ent in cytoplasmic vesicles , whose numbers were approximately doubled. Thus, the increase in cere brovascular permeability produced by histamine appears to involve predominantly pinocytotic mechanisms and enhanced vesicular transfer.
Vascular Pathology
Infla mmation
The participation of histamine in inflammatory and immune reactions has been recognized for many years (Wilhelm, 1962; Spector and Wil loughby , 1963; Zweifach, 1964; Hurley , 1972; Bourne et aI. , 1974; Lichtenstein and Gillespie , 1975; Beaven , 1978; Plaut , 1979) . (Hurley , 1972; Plaut , 1979) . The available histamine appears to have two types of effects that influence blood vessels: "pro-inflam matory" and "anti-inflammatory" actions (Plaut , 1979) . Pro-inflammatory actions of histamine are principally designed to increase local blood flow and vascular permeability to facilitate the migra tion of complement , primarily leukocytes and im munoglobins , from blood to the abluminal site of inflammation (Plaut and Lichtenstein, 1979) . Al most certainly, this is a transient , short-term pro cess because the release of mast cell contents is explosive (Feldberg and Paton , 1951) , and the syn- 1982 thesis and replenishment of histamine stores takes several days (Beaven, 1978) .
The anti-inflammatory action of histamine oper ates as a negative-feedback mechanism , e. g. , by in hibiting further histamine release from mast cells and basophils and by retarding lysosomal enzyme release from neutrophils (Plaut , 1979) . The two classes of histamine receptors can mediate indi vidually separate steps in the inflammation process (Plaut and Lichtenstein , 1979; Plaut , 1979) . For example, H2-receptors , which interact with the histamine released from mast cells (Powell and Brody, 1976a; Brody, 1980) , may be most important to pro-inflammatory reactions in blood vessels. It is interesting that adenylate cyclase , which in brain tissue and vascular preparations is sensitively acti vated by stimulation of histamine H2-receptors to form cyclic AMP (Schwartz, 1979; Karnushina et aI. , 1980 , McNeill, 1980 , is a critical modulator of leukocyte function in inflammatory and immune re sponses (Bourne et aI. , 1974 (Plaut and Lichtenstein , 1979) .
Hea dache
Histamine has been implicated as one of several important agents that induce migraine headache (Diamond et aI., 1976) . It may be involved espe cially in cluster headaches (Horton's headache , histaminic cephalgia) characterized by symptoms strongly resembling those produced by subcutane ous or intravenous administration of histamine , i.e. , lacrimation , conjunctival congestion , rhinorrhea , Horner's syndrome, throbbing pain, and an increase in skin temperature ipsilateral to the headache (Horton , 1941; Krabbe and Olesen , 1980) . Further more , circulating histamine levels are increased during bouts of cluster headache (Anthony and Lance, 1971) . These observations have led many investigators to believe that the primary events in histamine headache derive from cerebral vascular dilatation and increases in blood flow (Douglas, 1975; Diamond et aI. , 1976; Ryan and Ryan , 1978) . (Owen, 1977; Cuypers et aI., 1979) ; (4) the site from which histamine exerts its effect may not be readily determined or reached by clinical administration. If histamine is released perivascularly, for example, then pharmacological blockade by currently avail able H2-receptor antagonists may not be possible because these agents do not readily pass an intact blood-brain barrier (Anthony et aI., 1978; Schwartz, 1979 ).
Summary and Indications
The 
